2.69
2.69 (0%)
As of Feb 14, 2025
Protalix Biotherapeutics, Inc. [PLX]
Source:
Company Overview
Protalix Biotherapeutics, Inc is a commercial stage biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced via our proprietary ProCellEx plant cell-based protein expression system.
Country | United States |
Headquarters | hackensack, new jersey |
Phone Number | 201-696-9345 |
Industry | manufacturing |
CEO | Dror Bashan |
Website | http://www.protalix.com |